Article Details
Retrieved on: 2021-07-06 14:42:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
It will be run by Recipharm and the company told BioPharma-Reporter that it anticipates producing COVID-19 vaccines and biotherapeutics at the site.
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here